Lifemd, Inc. · NASDAQ:LFMD
Lifemd — Conversion Labs — Investor Presentation (September 2019)
17 slides from Lifemd's investor presentation, Sep 11, 2019
Slide 1: Conversion Labs
CONVERSIONLABS We’re advancing a new paradigm in health and wellness with technology
Slide 2: Safe Harbor
Safe Harbor Statements in this presentation that are not descriptions of historical facts are forward-looking statements relating to future events, and as such all forward-looking statements are made pursuant to the Securities Litigation Reform Act of 1995. Statements may contain certain forward-loo
Slide 3: Medical Questions
o — ' | Medical Questions At Conversion Labs, we enable a ; ; modern approach to wellness and 1 | crime verefornanrioes healthcare. i We are applying our direct response marketing expertise to healthcare and providing a convenient, cost-effective and smarter way for consumers to access high quality
Slide 4: Conversion Labs - An emerging leader in technology driven healthcare and telemedicine
Conversion Labs - An emerging leader in technology driven healthcare and telemedicine Deloitte's 2018 Technology Fast 500 publicly traded on revenue run-rate ad impressions licensed for online Rx OTCQB and growing served in 2 years & consults
Slide 5: Strong Revenue Growth & Financial Performance
Strong Revenue Growth & Financial Performance | ss Highlights Consistent Revenue Growth ($ in millions) $9,000,000.00 9 9 32% 93% $8,000,000.00 YOY Revenue Revenue CAGR Growth (2015-2019E) $7,000,000.00 $6,000,000.00 2g oO $5,000,000.00 = o tm 150,000+ $4,000,000.00 8 annene Customers $3,000,000.00
Slide 6: Proven direct-response marketing ability
Proven direct-response marketing ability $3,000,000.00 $450,000.00 $2,500,000.00 $400,000.00 $350,000.00 $2,000,000.00 $300,000.00 250,000.00 $1,500,000.00 8 $200,000.00 $1,000,000.00 $150,000.00 $100,000.00 $500,000.00 $50,000.00
Slide 7: Major consumer and healthcare trends are driving the growth of telemedicine and e-wellness
Major consumer and healthcare trends are driving the growth of telemedicine and e-wellness Healthcare Trends " Costs of healthcare rising due to aging = Convenience-focused: less willing to take population and poor public policy off work to wait in a clinic = Onaverage, it takes over two hours each
Slide 8: We are uniquely positioned for growth in direct response wellness and telemedicine
We are uniquely positioned for growth in direct response wellness and telemedicine Licensed for Rx and physician 2 upcoming brand (Rx) consults in all 50 states : launches in 2019 Proven direct-response Direct-to-Physician Rx marketing ability and OTC program
Slide 9: End-to-End telehealth customer acquisition model
End-to-End telehealth customer acquisition model 3. - Scheduling _ 4. - Consultation If required, a virtual visit with a - X Virtual visit with doctor, review of medical licensed physician is scheduled y 3 history, current medications 5. — Prescription Doctor to deny, approve or prescribe Rx, based
Slide 10: Our Business Units
Our Business Units Over-The-Counter Prescription Strategic Investments $1im Q3 2019 $3m run-rate and growing launch run-rate and growing
Slide 11: Over-the-counter brands
Over-the-counter brands SHAPIRO MD — HAIR GROWTH EXPERTS —— Developed by distinguished dermatologists Dr. Steven Shapiro, M.D., and Dr. Michael Borenstein, M.D., PhD 2 U.S. Patents; 15 years of product development and formulation work Includes naturally occurring DHT blocking system, FDA approved mi
Slide 12: Rx brands
Rx brands rex Male oriented telemedicine brand Initial product focus on erectile dysfunction; to be expanded to sores, skin & acne, and enlarged prostate treatments Global market for erectile dysfunction drugs expected to reach USD $2.95 billion by 2023 Synergistic with existing OTC customer base Pr
Slide 13: Strategic Investments
Strategic Investments CVLB acquired a 51% stake in PDFSimpli in June 2018. As of August 9, 2019, PDFSimpli was ranked in the top 29,000 websites globally and has more than 1.6M registered users globally. PDFSimpli has had over 6 terabytes of documents converted or edited by customers from the legal,
Slide 14: Peer Comparison
Peer Comparison . Market r P : Ro (roman/rory) Private Men/Women TeleRx $500 Million -$50M $173 Million+ Hims Private Men’s TeleRx $1 Billion ~$100 M $197 Million Thirty Madison (Keeps) Private Men’s Hair Loss Est. ~$50-100 M N/A $22.8 Million Lemonaid Health Private TeleRx/Counseling $60 M (18) Est
Slide 15: Financial Highlights
Financial Highlights Corporate Highlights Share Structure (September 1, 201 Shares Outstanding 52,969,262 Convertible Notes 6,468,838 Warrants 10,991,838 Options 19,245,000 Fully Diluted 89,674,938 Cash From Full Exercise of Options/Warrants $8,792,256.75 Stock Information Listing OTCQB Symbol CVLB
Slide 16: Management, board and advisors
Management, board and advisors Justin Schreiber Chairman John R. Strawn, Jr. Director Substantial retail, healthcare, e-commerce, M&A, Anthony G. Bruzzese, M.D. Director P a - ; and capital markets experience, serial Michael Borenstein, M.D. Dleaior entrepreneurs and venture capitalists with a track
Slide 17: Conversion Labs
CONVERSIONLABS Justin Schreiber Juan Manuel Pifieiro Dagnery Chairman & CEO (oe) justin@conversionlabs.com juan@conversionlabs.com NY: 800 Third Avenue, Suite 2800, New York, NY 10022 qe” CA: 5882 Bolsa Avenue, Suite 230, Huntington Beach, CA 92648 PR: 53 Calle Las Palmeras, Suite 802, San Juan, PR
Conversion Labs — Investor Presentation (September 2019) on 6ix